of enterprise generative AI pilots fail to prove measurable business impact (MIT NANDA, State of AI in Business 2025)
of pharma content reviewers don't trust AI to create regulatory compliant content (Klick Health / Momentum Events, 2025, n=40)
of HCPs and patients say social media and AI has changed how they learn about a treatment (Sermo, 2023)
The hardest question in pharma today
You're invested in AI. The harder question now is whether you can show it changed anything.
Being fast and being brilliant isn't enough if you can't trust the output.
It has to hold up when Medical, Legal or Regulatory reviews it, built on what patients and HCPs actually say, not assumptions that fall apart under scrutiny.
BRIANN turns real patient, HCP and audience conversations online into insight, strategy and tactics you can act on.
Every insight holds up.
A dedicated human specialist, your Audience Intelligence Engineer, validates the inputs and method, then makes sure the output is sound, actionable and compliant.
In Commercial
Best-in-class, consultancy-grade insight, strategy and tactics ready to use.
In Medical
Every insight sourced with transparent methodology.
In Compliance
Patient conversation can be anonymised before it reaches you if required.
Meet BRIANN
They read, watch and listen across the social conversation in your treatment area, then turn it into validated, decision-ready insight for pharma's hardest jobs. All with a dedicated human pharma specialist keeping the orchestra in tune and accountable.
BRIANN Module
Know what patients and HCPs are saying and which trends are taking hold in your therapy area, through pharma-tuned social listening and sentiment.
BRIANN Module
A verified shortlist of HCPs, patient advocates and organisations worth partnering with, scored on content, expertise and engagement.
BRIANN Module
Content and ideas analysed for risk against pharmaceutical guidelines, flagged before MLR review for faster cycles.
BRIANN Module
Understand exactly how your content resonates with your audience and how to improve it, benchmarked against competitor performance.
BRIANN Module
Measure, uncover and reverse-engineer exactly what your competitors are doing, and how well it resonates with the treatment-landscape audience.
BRIANN Module
Track how your brand, products and treatment area show up in AI-generated answers, and surface the gaps and misrepresentations worth fixing.
Coming Soon
A DEDICATED HUMAN PHARMA SPECIALIST
Every BRIANN account has a dedicated human pharma specialist, the Audience Intelligence Engineer (AIE), who keeps the orchestra in tune. One specialist can span all your markets, so you get consistency, accountability and local market flexibility.
Actionable, fast & defensible
Insight you can act on while it still matters, that holds up when Medical checks it, and moves the numbers you are measured on.
Time saved on data analysis. Insight returns in moments not weeks, with the recommendations, strategy and tactics attached. BRIANN is in the room while you are deciding, not a PDF that lands a month too late.
Higher engagement on data-led content. Built on what audiences actually say, not guesswork, and checked against local regulatory and internal guidelines as it is created, so the work performs and clears MLR pre-screen.
Faster DOL identification, verification and engagement. Key voices ranked by authority, reach and risk, with playbooks and outreach drafted, so you reach the people who move medical opinion.
What BRIANN does
Key tasks across Commercial, Medical, Communications and R&D, from measuring impact to competitive analysis and handling a crisis.
Built from the ground up for pharma
Pharma can't treat audience insight like other industries. It has to survive Medical, Legal and Regulatory review, anonymise online conversation, tell patients and HCPs apart, and never hallucinate. BRIANN is built around those requirements, not a consumer tool with compliance added later.
BRIANN strips PII from the incoming conversation before it reaches you, so pharmacovigilance, adverse-event and GDPR exposure is removed while tone and context are kept. The pre-screen protects the content; the mirror protects the data.
Pharma's biggest reason to distrust AI for critical work is hallucination, where models invent answers when they do not know. BRIANN is built to do the opposite: every insight can cite the exact conversation it came from, and where the data does not support a claim, BRIANN says so rather than fabricates one.
BRIANN checks text, image and video against the promotional codes for your market and your own loaded guidelines. It returns a traffic-light status, cites the exact clause each flag touches, and suggests a fix before a piece reaches review, not after.
WHERE BRIANN SITS
Your AI assistant can't see the social conversation, and can't touch it compliantly. BRIANN plugs in as an agent (via MCP), giving your AI a new, compliant audience-intelligence capability without anyone leaving the tool they already use.
A generic model only sees what a surface-level web search returns, not the full social conversation. When it doesn't have a solid answer, it hallucinates. BRIANN answers from comprehensive, sourced social data, so the output is grounded, not guessed.
Generic listening tools mask personal data but keep the raw posts, which regulators still treat as personal data. BRIANN destroys it at the source, it does not just hide it. It is built for pharma, not thousands of consumer brands: it tells patient and HCP conversation apart, where generic tools blur the two.
Traditional audience listening and research is slow, expensive and often thin on detail, context and actions you can use. BRIANN delivers the depth in days, sourced and ready to act on.
Specialist pharma tools do one job well, DOL discovery or insights management, and leave you to stitch six of them together. BRIANN runs the whole orchestra under one validation layer, on one subscription.
Seamlessly integrate into your existing AI capability
BRIANN meets your team where it already works.
The BRIANN insight platform gives your team a place to explore the data, run the jobs and drive BRIANN first-hand.
Reach BRIANN in Microsoft Teams or Slack and ask in plain language, like you would a human. No prompt engineering or new tools to learn, and every answer comes back pharma-tuned and validated.
BRIANN can sit as an agent inside your own AI via MCP, adding validated audience intelligence no general assistant can reach, without anyone leaving the system they already use.
BRIANN is LLM-agnostic, in your own environment, so no data leaves your own or your AI provider's walled garden.
90-Day Evaluation
Test BRIANN on your own therapeutic area, with your team and your dedicated specialist, before you commit.
Full access
The complete orchestra of agents, guided by your assigned specialist.
Your data, your therapeutic area
Real output on your brand, not a generic demo.
A clear path
$37,500 for a single market, 90 days. Convert to an annual subscription within 30 days and the full pilot fee is credited.
And BRIANN does not stop at the pilot. Once live it is always on: a what-changed-this-week digest lands automatically, with quarterly deep-dives built in, not a report you wait a quarter for.
You're not buying a promise. You're testing the output and deciding whether it proved anything.
Single market · 90 days
$37,500
— one-time pilot fee
Convert to an annual subscription within 30 days and the full pilot fee is credited.
BRIANN FAQ
BRIANN is an audience intelligence platform built for the pharmaceutical industry. An orchestra of AI agents reads, watches and listens across social conversation in your treatment area and turns it into validated, decision-ready insight, strategy and tactics. Every account includes a dedicated human pharma specialist, the Audience Intelligence Engineer, who validates inputs, method and output.
Generic social listening tools are built for thousands of consumer brands and mask personal data while keeping the raw posts, which regulators still treat as personal data. BRIANN is built only for pharma: it destroys personal data at the source rather than hiding it, tells patient and HCP conversation apart, and delivers insight designed to survive Medical, Legal and Regulatory review.
BRIANN strips personally identifiable information from incoming conversation before it reaches you, removing pharmacovigilance, adverse-event and GDPR exposure while keeping tone and context. Personal data is destroyed at the source, not masked. Patient conversation can be fully anonymised before it reaches your team if your compliance policy requires it.
BRIANN is built to do the opposite of a generic AI model. Every insight can cite the exact conversation it came from, and where the data does not support a claim, BRIANN says so rather than fabricating an answer. A dedicated human specialist validates the method and output on every account.
BRIANN is designed for it. Every insight is sourced with transparent methodology so Medical can trace it back to real patient and HCP conversation. The Compliance Checker module pre-screens content and ideas against the promotional codes for your market and your own loaded guidelines, returning a traffic-light status with the exact clause each flag touches, before MLR review rather than after.
The Audience Intelligence Engineer is the dedicated human pharma specialist on every BRIANN account. They configure your data capture, build the context layer around your role and therapy-area strategy, train BRIANN on relevance, personally answer anything you flag, and review output quality. One specialist can span all your markets for consistency and accountability.
BRIANN starts with a 90-day evaluation at $37,500 for a single market, with full access to every module, your own data and therapy area, and a dedicated Audience Intelligence Engineer. Convert to an annual subscription within 30 days of the pilot ending and the full pilot fee is credited.
Yes. BRIANN plugs into your own AI assistant as an agent via MCP, so your team gains compliant audience intelligence without leaving the tools they already use. It also works inside Microsoft Teams and Slack in plain language, through its own web platform, and is LLM-agnostic, so it can run in your own environment.
Yes. BRIANN distinguishes patient conversation from HCP conversation in your treatment area, where generic listening tools blur the two. That separation drives its pharma-specific outputs: patient insight for Commercial and Communications, HCP and DOL intelligence for Medical, each handled under the compliance rules that apply to that audience.
New · BRIANN Agentic
Your team reaches BRIANN without opening another platform. The pharma expertise comes to your AI assistant, and every answer arrives already checked.
Reach BRIANN from inside Microsoft Copilot, Veeva AI, Adobe or your own AI assistant. Nothing new to log into.
A real answer about your therapy area, not a generic web reply. Ask about trusted voices, share of voice, sentiment, competitors and congresses.
BRIANN labels each answer so your team instantly knows what is safe to act on and what still needs a human eye.
Anonymisation architecture
BRIANN listens to what your audience says in public. It destroys every identifier before analysis begins. Identity is removed, not masked: there is no key, and no reverse function. Anonymisation can be turned on or off per topic, across any listening topic of your choosing.
Irreversible · GDPR-safe output
01
Identifiers are stripped at ingest, in memory, before anything is stored. The original post is deleted within hours. There is no key to put it back, not by you, not by us.
02
An LLM rebuilds each post as a “digital mirror”: the style, context and meaning kept, every identifier irreversibly removed. You read what people mean, never who said it. The original wording is never stored.
03
No PII survives, so the output clears the strict bar regulators set for true anonymisation. Reversible masking does not, and regulators have ruled masked data is still personal data.
04
Every step is logged and explainable, so Medical, Legal and Regulatory can trace exactly how any output was produced. The audit trail is the architecture, not a document written after the fact.
How teams use BRIANN
Pharma teams use BRIANN for their toughest jobs, from measuring impact to pre-screening for MLR, each one running as a dedicated AI agent trained on millions of healthcare conversations and kept honest by a human pharma specialist. Every capability works across four functions. The line under each shows what it does for Commercial, Medical, Communications and R&D.
Where you show up in AI-generated answers, how you compare to competitors, and what moves your position.
Commercial Know what AI engines recommend when HCPs and patients ask about your brand and your competitors, and where to influence it.
Medical Check the engines describe your science and safety profile accurately, and flag what they get wrong.
Communications Monitor how AI answers frame your company and brand reputation, and correct the narrative the machines are spreading.
R&D Monitor how AI engines represent your mechanism, trial data and safety profile to researchers and patients, and flag where they get the science wrong.
Emerging topics, shifting sentiment and safety-adjacent signals, surfaced as they appear.
Commercial Spot rising themes and audience needs early, so campaigns ride the moment instead of chasing it.
Medical Surface real-world insight, off-label discussion and safety signals from the field.
Communications Catch a reputational issue or narrative shift while it is still small enough to shape.
R&D Detect emerging science, unmet need and the symptom language patients use, early signal for target and indication selection.
False claims and AI-generated noise about your brand, who is spreading it, and how fast it is moving.
Commercial Protect brand trust by catching false claims before they reach your audience.
Medical An early read on scientific misinformation, so the medical correction is ready before it spreads.
Communications Identify the source and spread of a false narrative early enough to respond.
R&D Catch where your science or trial data is being misread or misrepresented in the scientific conversation, before it sets.
Where you sit against competitors, where the gaps are, and the white space to take.
Commercial See your share of voice against competitors and where to take ground.
Medical Benchmark your scientific narrative against rivals and find the data-story white space.
Communications Benchmark corporate and brand reputation against competitors across channels.
R&D Read sentiment and momentum around a target, mechanism or competitor readout, and find the scientific white space.
What is trending, which opinion leaders are driving it, and where competitors stay silent.
Commercial See which sessions, brands and themes are driving congress buzz, and where your presence is landing.
Medical Track which data readouts and DOLs drive the conversation, and engage while it matters.
Communications Monitor congress narrative and media reaction in real time for rapid response.
R&D Track how a data readout lands with the scientific community and which investigators are driving the reaction.
Treatment experience, the drivers behind adherence, and the language patients use where they speak freely.
Commercial Build campaigns on the real patient experience and the words patients use, not assumptions.
Medical Turn patient-reported experience and unmet need into evidence for advisory boards and gap planning.
Communications Ground patient storytelling and advocacy messaging in authentic lived experience.
R&D Capture disease burden and the patient's own language to characterise the target population and inform endpoint choices.
Surface which outcomes are meaningful to patients, the real treatment burden, and where protocol or eligibility design will create friction, before the protocol locks. Grounded in patient-focused drug development, the framework regulators now expect.
Medical (adjacent) Feed patient-centred evidence into value stories and evidence-gap planning.
R&D Sharpen endpoint and COA/PRO selection and benefit-risk with real patient evidence, and improve feasibility before sites open.
Find where patient and caregiver communities actually gather, read the barriers and sentiment toward trial participation, and test acceptance of decentralised or hybrid designs.
R&D Improve recruitment and retention, surface representativeness and diversity gaps, and identify patient-advocacy partners for co-design.
Identify, tier and engage your Digital Opinion Leaders, with a personalised playbook for each.
Commercial Identify and engage the influential voices who shape brand perception in your category.
Medical Tier DOLs by scientific theme so MSLs reach the right experts with peer-credible exchange.
Communications Find the credible third-party voices to engage for advocacy and reputation.
R&D Map the investigators and digitally active scientific leaders in a disease area for site selection, advisory boards and scientific engagement.
How HCPs and patients respond, and how perception shifts over time.
Commercial Test campaign messages with your target audience before you commit media budget.
Medical Test how data messages land with DOLs and track how clinical perception shifts.
Communications Pre-test corporate and issue messaging for how it will be received.
R&D Pressure-test trial communications, lay summaries and protocol concepts with patient and investigator audiences before commitment.
Identify trial-active investigators and the digitally active scientific leaders driving a disease area, using trial history, publications and digital footprint together.
Medical (adjacent) Extends DOL mapping into the investigator community for scientific engagement.
R&D Support site selection, advisory-board composition and scientific-engagement planning with a live map of who matters and why.
BRIANN writes the brief, strategy and plan, ready for your agency or your own AI to run.
Commercial Brief campaigns and content on real audience evidence, ready for your agency or your own AI.
Medical Evidence-led scientific-engagement briefs grounded in what HCPs are actually discussing.
Communications Build comms and narrative briefs grounded in stakeholder sentiment.
R&D Build evidence-led patient-insight and feasibility inputs for protocol design and recruitment planning.
Messaging frameworks, press releases, quote options and media Q&A.
Commercial Turn audience language into campaign messaging, content and copy that lands.
Medical Medical narrative frameworks and scientific Q&A grounded in real HCP language.
Communications Press releases, quote options, media Q&A and messaging frameworks, ready to use.
R&D Turn patient and scientific language into plain-language trial materials, recruitment messaging and lay summaries.
Strategy, tactics, KPIs and compliance guardrails, refined until it is ready to run.
Commercial Turn a brand or campaign question into a full plan with KPIs and guardrails.
Medical Turn a scientific-engagement question into a planned approach with clear objectives and guardrails.
Communications Turn a reputational or narrative question into a structured comms plan.
R&D Turn a feasibility or endpoint question into a structured insight plan with clear objectives.
Checks text, image and video against your codes and SOPs, returns a traffic-light status and the fix, before review, not after.
Commercial Pre-screen campaign concepts and content against your codes, before review not after.
Medical Pre-screen for fair balance and substantiation, so reviewers spend their time on judgement, not triage.
Communications Pre-check public and media materials against your codes before they go out.
R&D Pre-check recruitment materials, lay summaries and patient-facing trial content against your codes before review.
Track it, read the sentiment, draft for either outcome, and prep your spokesperson.
Commercial Protect the brand through a live issue, with the facts and the response ready.
Medical Arm medical spokespeople with the science and the hardest questions, so the response holds up clinically.
Communications Track the story, draft for either outcome, and prep the spokesperson.
R&D Manage a scientific or trial reputational event, a safety question or a halted study, with the facts and the hardest questions ready.
Track share of voice and share of recommendation, before and after, and show the difference your work made.
Commercial Prove campaign impact on share of voice and engagement, before and after.
Medical Measure scientific share of voice and prove the impact of MSL and scientific exchange, not just promotional spend.
Communications Measure reputation and narrative shift before and after a programme.
R&D Track scientific reception and patient-community awareness before and after a readout or disclosure.
BRIANN runs continuously and alerts you the moment a conversation, benchmark or anomaly shifts.
Commercial Continuous alerts on brand conversation, competitor moves and campaign signals.
Medical A continuous medical-insights digest on rising debate, new DOL voices and safety shifts.
Communications Real-time alerts on reputational risk and emerging narratives.
R&D Continuous signal on emerging science, safety-adjacent chatter and competitor pipeline moves.
Listen for real-world adverse-event and tolerability discussion as an early, supplementary signal that feeds your safety team.
Medical (adjacent) Gives Medical Information an early read on real-world tolerability discussion.
R&D An early read on tolerability and real-world experience, a signal to investigate, fed to pharmacovigilance, not a substitute for formal case reporting.
These are AI agents, not AI experts. The expert is the human who guides them, your Audience Intelligence Engineer, who keeps the orchestra in tune and stands behind what comes out.
